8PXZ image
Entry Detail
PDB ID:
8PXZ
Title:
Crystal structure of the transpeptidase LdtMt2 from Mycobacterium tuberculosis in complex with natural substrate
Biological Source:
PDB Version:
Deposition Date:
2023-07-24
Release Date:
2024-08-07
Method Details:
Experimental Method:
Resolution:
1.98 Å
R-Value Free:
0.22
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:L,D-transpeptidase 2
Chain IDs:A
Chain Length:355
Number of Molecules:1
Biological Source:Mycobacterium tuberculosis
Polymer Type:polypeptide(D)
Description:Peptidoglycan tripeptide
Chain IDs:B
Chain Length:3
Number of Molecules:1
Biological Source:Corynebacterium jeikeium
Polymer Type:polypeptide(L)
Description:Peptidoglycan dipeptide
Chain IDs:C
Chain Length:2
Number of Molecules:1
Biological Source:Corynebacterium jeikeium
Primary Citation
Biochemical and crystallographic studies of L,D-transpeptidase 2 from Mycobacterium tuberculosis with its natural monomer substrate.
Commun Biol 7 1173 1173 (2024)
PMID: 39294212 DOI: 10.1038/s42003-024-06785-3

Abstact

The essential L,D-transpeptidase of Mycobacterium tuberculosis (LdtMt2) catalyses the formation of 3 → 3 cross-links in cell wall peptidoglycan and is a target for development of antituberculosis therapeutics. Efforts to inhibit LdtMt2 have been hampered by lack of knowledge of how it binds its substrate. To address this gap, we optimised the isolation of natural disaccharide tetrapeptide monomers from the Corynebacterium jeikeium bacterial cell wall through overproduction of the peptidoglycan sacculus. The tetrapeptides were used in binding / turnover assays and biophysical studies on LdtMt2. We determined a crystal structure of wild-type LdtMt2 reacted with its natural substrate, the tetrapeptide monomer of the peptidoglycan layer. This structure shows formation of a thioester linking the catalytic cysteine and the donor substrate, reflecting an intermediate in the transpeptidase reaction; it informs on the mode of entrance of the donor substrate into the LdtMt2 active site. The results will be useful in design of LdtMt2 inhibitors, including those based on substrate binding interactions, a strategy successfully employed for other nucleophilic cysteine enzymes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures